Boundless Bio, Inc. (BOLD)
NASDAQ: BOLD · Real-Time Price · USD
2.320
-0.060 (-2.52%)
At close: Nov 20, 2026, 4:00 PM EST
2.300
-0.020 (-0.86%)
After-hours: Nov 20, 2026, 4:38 PM EST
Boundless Bio Market Cap
Boundless Bio has a market cap or net worth of $54.78 million as of November 20, 2026. It is the 28,846th most valuable company in the world and the 4,434th biggest in the United States. Its market cap has increased by 112.79% in one year.
Market Cap
54.78M
Enterprise Value
-8.12M
1-Year Change
112.79%
Global Rank
Country Rank
#4,434 United States
Category
ChartMarket Cap Chart
Since the IPO on March 28, 2024, Boundless Bio's market cap has decreased from $355.83M to $54.78M, a decrease of -84.61%. That is a compound annual growth rate of -50.65%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2026 | 54.78M | 103.92% |
| Dec 31, 2025 | 26.86M | -58.46% |
| Dec 31, 2024 | 64.67M | -81.83% |
| Mar 28, 2024 (IPO) | 355.83M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Acrivon Therapeutics | 60.64M |
| OKYO Pharma | 60.35M |
| Fortress Biotech | 60.03M |
| Cognition Therapeutics | 57.23M |
| iBio, Inc. | 56.37M |
| Nordicus Partners | 56.37M |
| Milestone Pharmaceuticals | 56.36M |
| Azora Therapeutics | 54.86M |